CVKD vs NWL · $20.2M cap vs rev $3.54B
Cadrenal Therapeutics, Inc. Common Stock (CVKD) versus Newell Brands Inc (NWL) — a side-by-side from cached financials, not a winner call.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a biotechnology company listed on US.
Newell Brands Inc (NWL) is a household & personal products company listed on NASDAQ.
CVKD does not have a complete income-statement cache yet.
Latest reported NWL revenue for 2026-06-30 was $3.54B. Net income was $73.0M. NWL currently screens at market cap $2.11B.
CVKD currently screens at market cap $20.2M. NWL currently screens at market cap $2.11B.
Not investment advice. Open the CVKD and NWL stock pages for the full models.
Not investment advice.